A judge has denied Mylan’s bid to temporarily block Sun Pharma and Cipla from making generic versions of anti-cholesterol drug Lipidil while it appeals a ruling invalidating several claims of its patents for the drug, citing the “difficulty, complexity and uncertainty” in assessing compensation under an undertaking as to damages in pharmaceutical patent proceedings.
Deloitte can’t escape class action claims over failure of Dick Smith
Catch Group settles dispute with Kogan over ‘catch’ AdWords
QANTM waves white flag in Xenith takeover fight
Geoffrey Rush wins defamation case against Daily Telegraph publisher
IAG hit with class action over add-on insurance
ACCC brings criminal cartel charges against money transfer business
Judge fines CFMMEU, official for making a stink over dirty worksite toilet
ALRC to tackle ‘comprehensive’ review of corporate crime laws
Months after submitting its final report on the country’s class action regime, the Australian Law Reform Commission has been tasked with undertaking a “comprehensive” review of the effectiveness of the country’s corporate crime laws, including whether the criminal code should be altered to make senior executives liable for company misconduct.